Stock listing
RAD Stock Price, News, Filings & Events — Radiopharm Theranostics Limited
Selected listing: RAD · ASX · AUD · AU
This page tracks Radiopharm Theranostics Limited's RAD:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RAD:ASX. RAD:ASX is the stock-level entry point for investors researching Radiopharm Theranostics Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Radiopharm Theranostics Limited, trading under the ticker RAD, is a public company listed on the Australian market. The company has a market capitalization of approximately AUD 46.9 million. Radiopharm focuses on developing innovative radiopharmaceuticals for diagnostic and therapeutic applications in the healthcare sector.

- Ticker
- RAD:ASX
- Asset type
- Stock
- Market cap
- $31.2M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- ASX
- Currency
- AUD
Radiopharm Theranostics Limited RAD:ASX stock context
This page tracks Radiopharm Theranostics Limited's RAD:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RAD:ASX. RAD:ASX is the stock-level entry point for investors researching Radiopharm Theranostics Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Radiopharm Theranostics Limited, trading under the ticker RAD, is a public company listed on the Australian market. The company has a market capitalization of approximately AUD 46.9 million. Radiopharm focuses on developing innovative radiopharmaceuticals for diagnostic and therapeutic applications in the healthcare sector.
Latest news from Radiopharm Theranostics Limited
Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma
September 9, 2026
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid T...
August 26, 2026
RAD Doses First Patient in Second Cohort of BetaBart (RV-01)
August 25, 2026
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202...
August 20, 2026
RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial
August 19, 2026
Research Radiopharm Theranostics Limited
Radiopharm Theranostics Limited investor report
Review AI stock analysis and investor report context for RAD:ASX.
Radiopharm Theranostics Limited company profile
View the public company page for Radiopharm Theranostics Limited on 6ix.
Radiopharm Theranostics Limited news
Read company news and market updates connected to Radiopharm Theranostics Limited.
Radiopharm Theranostics Limited investor events
Find investor webinars, events, and replay context for Radiopharm Theranostics Limited.
Alternate listings
RADX:NASDAQ
US · USD
Alternate listing for Radiopharm Theranostics Limited; the primary context on this page is RAD:ASX.
RDPTF:OTC
US · USD
Alternate listing for Radiopharm Theranostics Limited; the primary context on this page is RAD:ASX.
RADX:BOATS
US · USD
Alternate listing for Radiopharm Theranostics Limited; the primary context on this page is RAD:ASX.